Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI

Stephanie Vos, Ineke A. van Rossum, Leah Burns, Dirk Knol, Philip Scheltens, Hilkka Soininen, Lars-Olof Wahlund, Harald Hampel, Magda Tsolaki, Lennart Minthon, Ron Handels, Gilbert L'Italien, Wiesje M. van der Flier, Pauline Aalten, Charlotte Teunissen, Frederik Barkhof, Kaj Blennow, Robin Wolz, Daniel Rueckert, Frans VerheyPieter Jelle Visser

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2272-2281
JournalNeurobiology of Aging
Volume33
Issue number10
DOIs
Publication statusPublished - Oct 2012

Keywords

  • Alzheimer's disease (AD)
  • Dementia
  • Mild cognitive impairment (MCI)
  • cerebrospinal fluid (CSF)
  • A beta 1-42
  • Tau
  • Magnetic resonance imaging (MRI)
  • Volumetry
  • Hippocampus
  • Diagnostic test sequence

Cite this

Vos, S., van Rossum, I. A., Burns, L., Knol, D., Scheltens, P., Soininen, H., Wahlund, L-O., Hampel, H., Tsolaki, M., Minthon, L., Handels, R., L'Italien, G., van der Flier, W. M., Aalten, P., Teunissen, C., Barkhof, F., Blennow, K., Wolz, R., Rueckert, D., ... Visser, P. J. (2012). Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI. Neurobiology of Aging, 33(10), 2272-2281. https://doi.org/10.1016/j.neurobiolaging.2011.12.017